Long-term survival after percutaneous irreversible electroporation of inoperable colorectal liver metastases
- PMID: 30643457
- PMCID: PMC6312065
- DOI: 10.2147/CMAR.S182091
Long-term survival after percutaneous irreversible electroporation of inoperable colorectal liver metastases
Abstract
Background: For colorectal liver metastases (CRLM) that are not amenable to surgery or thermal ablation, irreversible electroporation (IRE) is a novel local treatment modality and additional option.
Methods: This study is a retrospective long-term follow-up of patients with CRLM who underwent IRE as salvage treatment.
Results: Of the 24 included patients, 18 (75.0%) were male, and the median age was 57 (range: 28-75) years. The mean time elapsed from diagnosis to IRE was 37.9±37.3 months. Mean overall survival was 26.5 months after IRE (range: 2.5-69.2 months) and 58.1 months after diagnosis (range: 14.8-180.1 months). One-, three-, and five-year survival rates after initial diagnosis were 100.0%, 79.2%, and 41.2%; after IRE, the respective survival rates were 79.1%, 25.0%, and 8.3%. There were no statistically significant differences detected in survival after IRE with respect to gender, age, T- or N-stage at the time of diagnosis, size of metastases subject to IRE, number of hepatic lesions, or time elapsed between IRE and diagnosis.
Conclusion: For nonresectable CRLM, long-term survival data emphasize the value of IRE as a new minimally invasive local therapeutic approach in multimodal palliative treatment, which is currently limited to systemic or regional therapies in this setting.
Keywords: CRLM; colorectal cancer; irreversible electroporation; liver metastases; long-term; salvage treatment; survival.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures



Similar articles
-
Recurrent Colorectal Liver Metastases in the Liver Remnant After Major Liver Surgery-IRE as a Salvage Local Treatment When Resection and Thermal Ablation are Unsuitable.Cardiovasc Intervent Radiol. 2022 Feb;45(2):182-189. doi: 10.1007/s00270-021-02981-4. Epub 2021 Nov 10. Cardiovasc Intervent Radiol. 2022. PMID: 34757483 Free PMC article.
-
Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial).BMC Cancer. 2015 Oct 24;15:772. doi: 10.1186/s12885-015-1736-5. BMC Cancer. 2015. PMID: 26497813 Free PMC article. Clinical Trial.
-
Colorectal liver metastases: making the unresectable resectable using irreversible electroporation for microscopic positive margins - a case report.BMC Cancer. 2015 Apr 12;15:271. doi: 10.1186/s12885-015-1279-9. BMC Cancer. 2015. PMID: 25886376 Free PMC article.
-
Irreversible Electroporation for Liver Metastases from Colorectal Cancer: A Systematic Review.Cancers (Basel). 2023 Apr 24;15(9):2428. doi: 10.3390/cancers15092428. Cancers (Basel). 2023. PMID: 37173895 Free PMC article. Review.
-
Irreversible Electroporation for Colorectal Liver Metastases.Tech Vasc Interv Radiol. 2015 Sep;18(3):159-69. doi: 10.1053/j.tvir.2015.06.007. Epub 2015 Jun 18. Tech Vasc Interv Radiol. 2015. PMID: 26365546 Review.
Cited by
-
Local Treatments in the Unresectable Patient with Colorectal Cancer Metastasis: A Review from the Point of View of the Medical Oncologist.Cancers (Basel). 2021 Nov 25;13(23):5938. doi: 10.3390/cancers13235938. Cancers (Basel). 2021. PMID: 34885047 Free PMC article. Review.
-
Efficacy and safety of irreversible electroporation for malignant liver tumors: a systematic review and meta-analysis.Eur Radiol. 2021 Sep;31(9):6511-6521. doi: 10.1007/s00330-021-07742-y. Epub 2021 Feb 27. Eur Radiol. 2021. PMID: 33638687
-
Contemporary evidence on colorectal liver metastases ablation: toward a paradigm shift in locoregional treatment.Int J Hyperthermia. 2022;39(1):649-663. doi: 10.1080/02656736.2021.1970245. Int J Hyperthermia. 2022. PMID: 35465805 Free PMC article.
-
Image-Guided Ablation for Colorectal Liver Metastasis: Principles, Current Evidence, and the Path Forward.Cancers (Basel). 2021 Aug 4;13(16):3926. doi: 10.3390/cancers13163926. Cancers (Basel). 2021. PMID: 34439081 Free PMC article. Review.
-
Irreversible electroporation versus radiofrequency ablation for malignant hepatic tumor: A prospective single-center double-arm trial.J Interv Med. 2022 Mar 20;5(2):89-94. doi: 10.1016/j.jimed.2022.03.010. eCollection 2022 May. J Interv Med. 2022. PMID: 35936662 Free PMC article.
References
-
- Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. - PubMed
-
- Bosetti C, Levi F, Rosato V, et al. Recent trends in colorectal cancer mortality in Europe. Int J Cancer. 2011;129(1):180–191. - PubMed
-
- Prenen H, Van Cutsem E. Oncological management of unresectable liver metastases. Dig Dis. 2012;30(Suppl 2):137–142. - PubMed
LinkOut - more resources
Full Text Sources